NCT01353274 is a clinical trial of Micamlo in Hypertension, sponsored by Boehringer Ingelheim.

Who is sponsoring NCT01353274?

NCT01353274 is sponsored by Boehringer Ingelheim.

What drugs are being tested in NCT01353274?

Interventions in NCT01353274: Micamlo.

What condition does NCT01353274 study?

NCT01353274 studies Hypertension.

Is NCT01353274 still recruiting?

NCT01353274 is currently completed. Last updated 30 July 2014.

Are results published for NCT01353274?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2014-07-30 · How we verify

NCT01353274

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Survey on Drug Use of Micamlo Combination Tablets AP in Patients With Hypertension

Completed Results posted Last updated 30 July 2014

What this trial tests

trial testing Micamlo in Hypertension in 1,157 participants. Completed in 1 August 2013.

Timeline

1 May 2011

Primary endpoint
1 August 2013

1 August 2013

Quick facts

Lead sponsor	Boehringer Ingelheim
Status	Completed
Study type	OBSERVATIONAL
Enrollment	1,157
Start date	1 May 2011
Primary completion	1 August 2013
Estimated completion	1 August 2013
Sites	254 locations across Japan

Drugs / interventions tested

Micamlo — full drug profile →

Conditions studied

Hypertension — all drugs for Hypertension →

Sponsor

Boehringer Ingelheim — full company profile →

Who can join

Eligibility, any sex, with Hypertension. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Incidence of Drug-related Adverse Events
Time frame: 12 months
Number of patients with drug-related adverse events

Sponsor's own description

Investigation of safety and efficacy of daily use of Micamlo Combination Tablets AP in patients with Hypertension

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Long-term safety and efficacy of telmisartan/amlodipine single pill combination in the treatment of hypertension.
Billecke SS, Marcovitz PA. · · 2013 · cited 7× · PMID 23662062 · DOI 10.2147/vhrm.s40963

Verify or expand the search:

Other recruiting trials for Hypertension

Currently open trials in the same condition.

NCT07413159 — The "Check, Monitor, Control Hypertension" Study is a 24-month Randomized Trial in Houston Targeting African Americans A · NA · recruiting
NCT07361276 — Observational Study That Will Evaluate Treatment Patterns in the Management of Hypertension in the Public Primary Care S · recruiting
NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · NA · recruiting
NCT07238400 — Cardiac Effects of Mineralocorticoid Receptor Antagonism After Preeclampsia · Phase 2 · recruiting
NCT07135505 — Early Time-Restricted Eating in Older Adults With Hypertension · NA · recruiting

Other Boehringer Ingelheim trials

Trials by the same sponsor.

NCT07044700 — Real-world Comparative Effectiveness and Safety of Jardiance in Chinese Patients With Heart Failure of Reduced Ejection · not yet recruiting
NCT07047508 — Real-world Study to Describe the Effectiveness and Safety Outcomes of Jardiance in Chinese Patients With Heart Failure a · not yet recruiting
NCT07366034 — A Study to Find Out How Nerandomilast is Tolerated, Handled by the Body, and if it Helps Children and Adolescents With I · Phase 3 · not yet recruiting
NCT07531628 — A Study to Test How Verducatib is Taken up in the Body of Healthy Chinese Participants · Phase 1 · not yet recruiting
NCT07497087 — A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis · Phase 3 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01353274 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Boehringer Ingelheim
Last refreshed: 30 July 2014

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01353274.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing